Friday, June 6, 2008

FDA Update, 6/6/2008

New and Generic Drug Approvals

carbidopa and levodopa tablets, Apotex Corp., Approval
carbinoxamine maleate tablets, Boca Pharmacal, Inc., Approval
moexipril hydrochloride tablets, Apotex Corp., Approval
potassium chloride extended-release capsules, Andrx Pharmaceuticals, LLC, Approval
propranolol hydrochloride tablets, Ipca Laboratories, Ltd., Approval
Sprycel (dasatinib) Tablets, Bristol-Myers Squibb Co., Control Supplement
Stavudine oral solution, Aurobindo Pharma USA, Inc., Tentative Approval
Tradename To Be Determined (mesalamine) Delayed-Release Tablets, Procter & Gamble Pharmaceuticals, Approval

1 comment:

Anonymous said...

Dear Author www.mtinsider.net !
I confirm. All above told the truth. Let's discuss this question.